Purpose: Developing a DNA dot hybridization model for diagnosing parasitic keratitis.

Methods: Newly designed oligonucleotide probes for detecting and microsporidia were tested with target reference strains of (n = 20) and microsporidia (n = 3), and non-target microorganisms, including bacteria (n = 20) and fungi (n = 20). These probes, which had passed the preliminary tests, were then assembled as a parasite dot hybridization (PDH) model for assessing 33 clinical samples from patients with clinically suspected and microsporidia keratitis, including eight positives for , 13 positives for microsporidia, and 12 negatives for both pathogens.

Results: Two probes for detecting and two for detecting microsporidia passed the tests using target and non-target strains and then were assembled in the PDH model. For clinical samples, one -positive sample (proved with pathology) was falsely negative according to the PDH assay. The sensitivity and specificity of the PDH assay for diagnosing keratitis were 87.5% and 100%, respectively, while the sensitivity and specificity for diagnosing microsporidia keratitis were 100%. The infectious agent of all clinical samples of microsporidia keratitis was identified as with DNA sequencing, while those of keratitis were caused by four species of , with found in four samples (50%, 4/8).

Conclusions: The PDH model has the potential to be a molecular assay for diagnosing and microsporidia keratitis. However, a prospective clinical study might be needed before the model is adopted in routine clinical practice.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568909PMC

Publication Analysis

Top Keywords

microsporidia keratitis
16
dot hybridization
12
pdh model
12
clinical samples
12
dna dot
8
hybridization model
8
probes detecting
8
microsporidia
8
detecting microsporidia
8
pdh assay
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!